News
Celyad Receives Additional €2.5 Million in Non-Dilutive Funding
Celyad Announces Board of Directors Evolution with New Appointment
Celyad Announces Board of Directors Evolution with New Appointment
Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights
Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights
Celyad Announces Closing of $20 Million Global Offering
Celyad Announces Closing of $20 Million Global Offering
Celyad Announces Pricing of $20.0 Million Global Offering
Celyad Announces Pricing of $20.0 Million Global Offering
Celyad Announces Launch of Proposed Global Offering
Celyad Announces Launch of Proposed Global Offering
Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights
Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights
Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights
Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights
Celyad Reports Business Update and Full Year 2018 Financial and Operating Results
Celyad Reports Business Update and Full Year 2018 Financial and Operating Results
Celyad Appoints Filippo Petti as Chief Executive Officer
Celyad Appoints Filippo Petti as Chief Executive Officer
Celyad Announces Third Quarter 2018 Business Update
Celyad Announces Third Quarter 2018 Business Update
Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting
Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting